PTAB Law Blog

The PTAB Law Blog, published by Rothwell Figg, focuses on developments and analysis related to the Patent Trial and Appeal Board (PTAB) proceedings, including inter partes review (IPR), post grant review (PGR), and other patent post-grant challenges. It covers procedural changes, discretionary denial policies, claim construction issues, and Federal Circuit decisions impacting PTAB practice. The blog discusses strategic considerations for patent practitioners, updates on USPTO policies, and case law interpretations relevant to patent litigation and administrative patent trials. It serves as a resource for understanding the evolving landscape of patent trial practice before the PTAB and related appellate decisions.

The battle over foundational CRISPR-Cas9 patent rights has reached another milestone. In March 2026, the Patent Trial and Appeal Board (PTAB) reaffirmed its priority determination in favor of the Broad Institute in Interference No. 106,115, concluding once again that the